NCT05837650Completed
Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment
Feasibility and Preliminary Efficacy of Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment - Randomized Controlled Pilot Study
Source: ClinicalTrials.gov · Last updated 26 Nov 2025
Brief summary (registry, in English)
This study tests the effect of a new behavioral intervention, Emotional Awareness and Expression Therapy (EAET), as a possible new treatment for people living with migraine. The main questions it aims to answer are: Can EAET lower the frequency and severity of migraine attacks? What are the elements that can explain EAET's effect? Requirements from Participants: Participants will be randomized into either a treatment or control arms. Those who are assigned to the control arm are eligible to receive the treatment in the next cohort. Participants assigned to the treatment arms are expected to engage in 8 weekly online sessions via Zoom (sessions are 2 hours long). Each session has a lecture, in-class exercises, discussion, and weekly assignments. Each participant is required to fill out questionnaires before the first session, and after the last session of the treatment. Participants will benefit from a new and promising intervention that can significantly help with their migraines at no cost.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 19 Apr 2023
- Start date
- 1 Apr 2023
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- University of Utah
- Diseases
- Migraine
- NCT number
- NCT05837650
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Apr 2023 to the primary completion date, 31 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- A diagnosis of medication overuse headaches.
- Changes in migraine medication in the past 3 months.
Other illness
- Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications.
- Untreated alcohol or substance use disorder.
- Substantial cognitive impairment.
- Failure to complete at least 85% of the daily diaries during the baseline 30-day diary assessment.
Other
- Active suicidal ideation.
- Risk of violent behavior.
- Enrollment in another treatment study.
- Current involvement in health-related litigation or disability application.
- Inability to use a computer and/or smartphone.
- limited access to the internet.
- Inability to communicate in English.
Who the study is looking for
- Adults of all genders, ages 18-80.
- A diagnosis of either episodic or chronic migraine (with or without aura) by a licensed neurologist.
- A migraine disability assessment scores higher than 6.
- A stable medication regimen for a minimum of 3 months.
- Must have had migraines for at least 1 year.
- Must have a minimum of 4 migraine days per month.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dan Kaufmann Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.